AdvanCell Expands Leadership Team with the Appointment of Christopher Horvath, MS MBA, as Chief Commercial Officer & Chief Operating Officer and Gary Li, PhD, as Chief Strategy Officer
AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer
AdvanCell Announces First Patient Dosed in Phase I/II Trial of 212Pb-ADVC001
POINT Biopharma Global Inc., a company developing radiopharmaceuticals, and AdvanCell, a company developing an innovative pipeline of targeted alpha therapies with a platform technology to produce 212Pb radiopharmaceuticals, entered into a collaboration on the development of a global 212Pb radioisotope and radiolig and supply chain and drug manufacturing network to specifically support the clinical development and commercialization of 212Pb-labeled radioligands by each company.